Cannell Capital’s Amedisys AMED Stock Holding History

Cannell Capital’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-14,739	Closed	-$171K	–	75
2013 Q2	$171K	Buy	+14,739	New	+$169K	0.1%	64

Other funds holding AMED

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCA

KKR Credit Advisors San Francisco, California $796M AUM

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cannell Capital's AMED Position: Q3 2013 in Review

Cannell Capital sold out of Amedisys (AMED) in Q3 2013, closing a stake of 14,739 shares — an estimated $171K sold.

Cannell Capital first reported a position in AMED in Q2 2013 and held it in 1 quarter. The position peaked at $171K in Q2 2013. 130 funds tracked by Wall St. Rank hold AMED as of Q3 2013.

Cannell Capital reported no remaining Amedisys position as of Q3 2013 after selling out during the quarter.
Cannell Capital sold 14,739 Amedisys shares in Q3 2013, an estimated $171K.
Cannell Capital first reported a position in Amedisys in Q2 2013 and held it in 1 quarter.
Cannell Capital's Amedisys position peaked at $171K in Q2 2013.
130 funds tracked by Wall St. Rank held Amedisys as of Q3 2013.

Based on Cannell Capital's 13F filing for Q3 2013, filed 14 Nov 2013.